REYON Pharmaceutical Co., Ltd. (KRX: 102460)

REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	257,874	303,360	384,347	631,111	390,433	264,446
Market Cap Growth	-17.74%	-21.07%	-39.10%	61.64%	47.64%	15.07%
Enterprise Value	473,153	498,164	550,681	726,725	401,156	228,088
Last Close Price	14060.00	16540.00	21446.14	34975.15	21584.40	15173.35
PE Ratio	-	84.82	52.67	114.67	95.61	51.72
PS Ratio	1.75	2.01	2.50	4.42	3.00	2.01
PB Ratio	1.04	1.22	1.55	2.57	1.70	1.19
P/TBV Ratio	1.02	1.23	1.56	2.59	1.71	1.22
P/OCF Ratio	94.09	35.09	44.03	54.01	84.89	-
EV/Sales Ratio	3.18	3.30	3.57	5.09	3.09	1.73
EV/EBITDA Ratio	103.55	76.00	61.31	117.02	64.51	21.30
EV/EBIT Ratio	248.52	281.00	123.80	470.45	242.52	34.44
EV/FCF Ratio	-21.30	-	-	-	-	-
Debt / Equity Ratio	0.90	0.91	0.85	0.85	0.26	0.15
Debt / EBITDA Ratio	36.02	34.33	23.40	33.38	9.56	3.14
Asset Turnover	0.30	0.31	0.32	0.36	0.44	0.46
Inventory Turnover	2.23	2.25	2.60	2.35	2.22	2.59
Quick Ratio	0.36	0.51	1.63	2.91	1.83	3.21
Current Ratio	0.65	0.79	2.27	3.47	2.42	3.94
Return on Equity (ROE)	-0.04%	1.44%	3.02%	2.33%	1.70%	2.21%
Return on Assets (ROA)	0.23%	0.23%	0.58%	0.24%	0.35%	1.44%
Return on Capital (ROIC)	0.24%	0.24%	0.61%	0.26%	0.38%	1.61%
Earnings Yield	-0.04%	1.18%	1.93%	0.88%	0.98%	1.87%
FCF Yield	-8.61%	-6.67%	-14.15%	-16.68%	-12.22%	-23.87%
Dividend Yield	1.02%	0.91%	0.70%	0.71%	0.93%	2.26%
Payout Ratio	0.00%	76.41%	61.39%	62.56%	150.47%	167.08%
Buyback Yield / Dilution	0.90%	-0.46%	-3.03%	-4.05%	-1.01%	0.80%
Total Shareholder Return	1.93%	0.44%	-2.33%	-3.34%	-0.09%	3.07%

Source: S&P Capital IQ. Standard template. Financial Sources.